A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT06508658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06508658
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-13
- Primary completion
- 2028-03-01
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.